Appointment of Dr. Alaka Keshav Deshpande (DIN:11238406) as an Additional Woman Independent Director, subject to the members approval in the ensuing 52th Annual General Meeting.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has appointed Dr. Alaka Keshav Deshpande (DIN: 11238406) as an Additional Woman Independent Director, effective September 27, 2025, for a three-year term ending September 26, 2028. The appointment is subject to shareholder approval through a special resolution at the upcoming 52nd Annual General Meeting. Dr. Deshpande is a medical professional with an MBBS and MD in General Medicine, with extensive experience including roles as Professor and Head of Medicine at Grant Medical College and affiliations with BARC and Hinduja Hospital. She is not related to any existing director or key managerial personnel, and is not debarred from holding a directorship by SEBI or any other authority.
This is a routine governance appointment, likely aimed at meeting regulatory requirements for having a woman independent director on the board. It is unlikely to have a material impact on the stock price or shareholder value, as no operational or strategic change is indicated.